| Acinetobacter baumannii |
Acinetobacter baumannii |
Inhibition |
30.13 |
% |
10.6019/CHEMBL4513141 |
| Candida albicans |
Candida albicans |
Inhibition |
1.12 |
% |
10.6019/CHEMBL4513141 |
| Cenchrus americanus |
Cenchrus americanus |
Activity |
42.0 |
% |
10.1016/j.cropro.2007.02.012 |
| Cenchrus americanus |
Cenchrus americanus |
Activity |
90.0 |
% |
10.1016/j.cropro.2007.02.012 |
| Cenchrus americanus |
Cenchrus americanus |
Activity |
nan |
None |
10.1016/j.cropro.2007.02.012 |
| Cryptococcus neoformans |
Cryptococcus neoformans |
Inhibition |
-7.28 |
% |
10.6019/CHEMBL4513141 |
| Enterococcus faecalis |
Enterococcus faecalis |
Activity |
nan |
None |
10.1021/jm00213a023 |
| Equus caballus |
Ferritin light chain |
Potency |
12589.3 |
nM |
None |
| Escherichia coli |
Dihydrofolate reductase |
Kd |
810.0 |
nM |
10.1021/jm00396a019 |
| Escherichia coli |
Dihydrofolate reductase |
Kd |
4400.0 |
nM |
10.1021/jm00396a019 |
| Escherichia coli |
Dihydrofolate reductase |
Kd |
4800.0 |
nM |
10.1021/jm00396a019 |
| Escherichia coli |
Escherichia coli |
Inhibition |
-0.13 |
% |
10.6019/CHEMBL4513141 |
| Escherichia coli (strain K12) |
Bifunctional protein FolC |
Inhibition |
nan |
% |
10.1038/nchembio.108 |
| Giardia intestinalis |
Putative fructose-1,6-bisphosphate aldolase |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
15-hydroxyprostaglandin dehydrogenase [NAD+] |
Potency |
35481.3 |
nM |
None |
| Homo sapiens |
Adenosine A1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A2a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Adenosine A3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Aldehyde dehydrogenase 1A1 |
Potency |
15848.9 |
nM |
None |
| Homo sapiens |
Aldose reductase |
IC50 |
52500.0 |
nM |
10.1016/j.bmcl.2016.09.033 |
| Homo sapiens |
Alpha-1a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2a adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2b adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-2c adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Alpha-galactosidase A |
Potency |
22387.2 |
nM |
None |
| Homo sapiens |
Alpha-synuclein |
Potency |
3981.1 |
nM |
None |
| Homo sapiens |
ATP-binding cassette sub-family C member 11 |
Activity |
nan |
None |
10.1124/mol.104.007138 |
| Homo sapiens |
ATP-binding cassette sub-family G member 2 |
Activity |
nan |
None |
None |
| Homo sapiens |
Beta-1 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-2 adrenergic receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Beta-glucocerebrosidase |
Potency |
22387.2 |
nM |
None |
| Homo sapiens |
Bile salt export pump |
AC50 |
300000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Bile salt export pump |
IC50 |
1000000.0 |
nM |
10.1002/hep.27206 |
| Homo sapiens |
Bile salt export pump |
IC50 |
1000000.0 |
nM |
10.1124/dmd.112.047068 |
| Homo sapiens |
Cannabinoid CB1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
CCRF-CEM |
Ki |
8950.0 |
nM |
10.1021/jm00040a008 |
| Homo sapiens |
CCRF-CEM |
Ki |
167000.0 |
nM |
10.1021/jm00040a008 |
| Homo sapiens |
Cholecystokinin A receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cyclooxygenase-2 |
AC50 |
16000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Cytochrome P450 1A2 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C19 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2C9 |
FC |
0.6 |
None |
10.1016/j.bmcl.2016.06.088 |
| Homo sapiens |
Cytochrome P450 2D6 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 2D6 |
FC |
0.6 |
None |
10.1016/j.bmcl.2016.06.088 |
| Homo sapiens |
Cytochrome P450 3A4 |
AC50 |
nan |
None |
None |
| Homo sapiens |
Cytochrome P450 3A4 |
FC |
0.6 |
None |
10.1016/j.bmcl.2016.06.088 |
| Homo sapiens |
Delta opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dihydrofolate reductase |
Activity |
nan |
None |
10.1021/acs.jmedchem.8b01711 |
| Homo sapiens |
DNA-(apurinic or apyrimidinic site) lyase |
Potency |
35481.3 |
nM |
None |
| Homo sapiens |
DNA polymerase beta |
Potency |
100000.0 |
nM |
None |
| Homo sapiens |
Dopamine D1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D2 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine D3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Dopamine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Endoplasmic reticulum-associated amyloid beta-peptide-binding protein |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
Endoplasmic reticulum-associated amyloid beta-peptide-binding protein |
Potency |
25118.9 |
nM |
None |
| Homo sapiens |
Endothelin receptor ET-A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Equilibrative nucleoside transporter 1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Estrogen receptor alpha |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Folate receptor alpha |
Inhibition |
nan |
% |
10.1021/jm401139z |
| Homo sapiens |
Folate receptor alpha |
Inhibition |
nan |
% |
10.1021/jm501113m |
| Homo sapiens |
Folate receptor beta |
Inhibition |
nan |
% |
10.1021/jm401139z |
| Homo sapiens |
Folate receptor beta |
Inhibition |
nan |
% |
10.1021/jm501113m |
| Homo sapiens |
Folylpoly-gamma-glutamate synthetase |
Km |
104600.0 |
nM |
10.1021/jm00113a011 |
| Homo sapiens |
Folylpoly-gamma-glutamate synthetase |
Vmax |
80.0 |
% |
10.1021/jm00113a011 |
| Homo sapiens |
Gamma-aminobutyric acid receptor subunit alpha-1/alpha-2/beta-2/gamma-2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Ghrelin receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Glucagon-like peptide 1 receptor |
Potency |
7079.5 |
nM |
None |
| Homo sapiens |
Glucocorticoid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
HERG |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H1 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histamine H3 receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-37.85 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Histone deacetylase 6 |
Inhibition |
-1.03 |
% |
10.6019/CHEMBL4808148 |
| Homo sapiens |
Homo sapiens |
Activity |
nan |
None |
10.1002/hep.27206 |
| Homo sapiens |
Homo sapiens |
Cmax |
135.0 |
nM |
10.1002/hep.27206 |
| Homo sapiens |
Homo sapiens |
DILI_Concern |
nan |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
Homo sapiens |
DILI_severity_class |
0.0 |
None |
10.1016/j.drudis.2016.02.015 |
| Homo sapiens |
IGROV-1 |
Activity |
nan |
None |
10.1016/j.bmcl.2019.05.047 |
| Homo sapiens |
KB |
Activity |
nan |
None |
10.1016/j.bmcl.2019.05.047 |
| Homo sapiens |
KB |
Concentration |
50.0 |
uM |
10.1021/jm040187v |
| Homo sapiens |
KB |
IC50 |
500.0 |
nM |
10.1021/jm4009168 |
| Homo sapiens |
Lysine-specific demethylase 4D-like |
Potency |
10000.0 |
nM |
None |
| Homo sapiens |
Lysine-specific demethylase 4D-like |
Potency |
25118.9 |
nM |
None |
| Homo sapiens |
Lysosomal alpha-glucosidase |
Potency |
50118.7 |
nM |
None |
| Homo sapiens |
MCF7 |
Activity |
nan |
None |
10.1016/j.bmcl.2019.05.047 |
| Homo sapiens |
Melanocortin receptor 3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Menin/Histone-lysine N-methyltransferase MLL |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
MOLT-4 |
IC50 |
100000.0 |
nM |
10.1021/jm00113a011 |
| Homo sapiens |
Monoamine oxidase A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Motilin receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Multidrug resistance associated protein |
Km |
1960000.0 |
nM |
None |
| Homo sapiens |
Multidrug resistance-associated protein 4 |
Activity |
45.0 |
% |
None |
| Homo sapiens |
Multidrug resistance-associated protein 4 |
Activity |
63.0 |
% |
10.1053/jhep.2003.50331 |
| Homo sapiens |
Multidrug resistance-associated protein 4 |
Km |
170000.0 |
nM |
None |
| Homo sapiens |
Mu opioid receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M1 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M2 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Muscarinic acetylcholine receptor M3 |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Neuronal acetylcholine receptor protein alpha-4 subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Norepinephrine transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Nuclear factor erythroid 2-related factor 2 |
Potency |
11582.1 |
nM |
None |
| Homo sapiens |
Peroxisome proliferator-activated receptor gamma |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 3A |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Phosphodiesterase 4D |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Pregnane X receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Progesterone receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serine hydroxymethyltransferase, mitochondrial |
Inhibition |
53.6 |
% |
None |
| Homo sapiens |
Serotonin 1a (5-HT1a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2a (5-HT2a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2b (5-HT2b) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 2c (5-HT2c) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin 3a (5-HT3a) receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Serotonin transporter |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Solute carrier family 22 member 1 |
Inhibition |
33.0 |
% |
10.1021/jm8003152 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B1 |
Inhibition |
98.4 |
% |
10.1124/mol.112.084152 |
| Homo sapiens |
Solute carrier organic anion transporter family member 1B3 |
Inhibition |
109.71 |
% |
10.1124/mol.112.084152 |
| Homo sapiens |
Sphingomyelin phosphodiesterase |
Potency |
25118.9 |
nM |
None |
| Homo sapiens |
Thymidylate synthase |
IC50 |
290000.0 |
nM |
10.1021/jm00387a016 |
| Homo sapiens |
Thymidylate synthase |
Ki |
40000.0 |
nM |
10.1021/jm00387a016 |
| Homo sapiens |
Thyroid stimulating hormone receptor |
Potency |
7943.3 |
nM |
None |
| Homo sapiens |
Type-1 angiotensin II receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
Ubiquitin carboxyl-terminal hydrolase 1 |
Potency |
39810.7 |
nM |
None |
| Homo sapiens |
Vasopressin V1a receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Klebsiella pneumoniae |
Klebsiella pneumoniae |
Inhibition |
12.05 |
% |
10.6019/CHEMBL4513141 |
| Mus musculus |
Folylpoly-gamma-glutamate synthetase |
k |
1.0 |
None |
10.1021/jm00127a019 |
| Mus musculus |
Folylpoly-gamma-glutamate synthetase |
Km |
234000000000.0 |
nM |
10.1021/jm00145a012 |
| Mus musculus |
Folylpoly-gamma-glutamate synthetase |
Km app |
1.0 |
rel |
10.1021/jm00145a012 |
| Mus musculus |
Folylpoly-gamma-glutamate synthetase |
Km app |
140.0 |
None |
10.1021/jm00127a019 |
| Mus musculus |
Folylpoly-gamma-glutamate synthetase |
Relative Vmax |
1.0 |
None |
10.1021/jm00145a012 |
| Mus musculus |
Folylpoly-gamma-glutamate synthetase |
Vmax |
1.0 |
None |
10.1021/jm00127a019 |
| Mus musculus |
L1210 |
IC50 |
10000000.0 |
nM |
10.1021/jm00085a010 |
| Mus musculus |
L1210 |
Inhibition |
33.6 |
% |
10.1021/jm00085a010 |
| Mus musculus |
L1210 |
Inhibition |
nan |
% |
10.1021/jm00085a010 |
| Mus musculus |
L1210 |
Tritium release |
19.1 |
% |
10.1021/jm00085a010 |
| Mus musculus |
L1210 |
Tritium release |
20.6 |
% |
10.1021/jm00085a010 |
| Mus musculus |
L1210 |
Tritium release |
21.8 |
% |
10.1021/jm00085a010 |
| Mus musculus |
L1210 |
Tritium release |
24.1 |
% |
10.1021/jm00085a010 |
| Mus musculus |
Solute carrier family 22 member 6 |
Activity |
nan |
None |
10.1074/jbc.274.3.1519 |
| Mus musculus |
Thymidylate synthase |
IC50 |
180000.0 |
nM |
10.1021/jm00157a600 |
| Mus musculus |
Thymidylate synthase |
IC50 |
1000000.0 |
nM |
10.1021/jm00157a600 |
| Plasmodium falciparum |
Plasmodium falciparum |
Potency |
293.6 |
nM |
None |
| Pseudomonas aeruginosa |
Pseudomonas aeruginosa |
Inhibition |
13.94 |
% |
10.6019/CHEMBL4513141 |
| Rattus norvegicus |
Androgen Receptor |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Cyclooxygenase-1 |
AC50 |
10000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
GABA receptor alpha-1 subunit |
AC50 |
30000.0 |
nM |
10.1038/s41467-023-40064-9 |
| Rattus norvegicus |
Liver |
IC50 |
nan |
None |
10.1002/hep.27206 |
| Rattus norvegicus |
Solute carrier family 22 member 6 |
Activity |
nan |
None |
10.1016/s0014-5793(98)01328-3 |
| Rattus norvegicus |
Solute carrier organic anion transporter family member 1A3 |
Activity |
nan |
None |
10.1074/jbc.271.34.20719 |
| Rattus norvegicus |
Solute carrier organic anion transporter family member 1A3 |
Activity |
nan |
None |
None |
| Rattus norvegicus |
Solute carrier organic anion transporter family member 1A3 |
Ki |
14100.0 |
nM |
None |
| Severe acute respiratory syndrome coronavirus 2 |
Replicase polyprotein 1ab |
Inhibition |
20.75 |
% |
10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Hit score |
0.1591 |
None |
10.1101/2020.04.21.054387 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
19952.62 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
IC50 |
20000.0 |
nM |
10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
0.07 |
% |
10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition |
2.02 |
% |
10.21203/rs.3.rs-23951/v1 |
| Severe acute respiratory syndrome coronavirus 2 |
SARS-CoV-2 |
Inhibition index |
0.02238 |
None |
10.1101/2020.04.03.023846 |
| Staphylococcus aureus |
Staphylococcus aureus |
Inhibition |
10.57 |
% |
10.6019/CHEMBL4513141 |
| Sus scrofa |
Sus scrofa |
Km |
7700.0 |
nM |
10.1021/jm00127a026 |
| Sus scrofa |
Sus scrofa |
Km |
93000.0 |
nM |
10.1021/jm00127a026 |
| Sus scrofa |
Sus scrofa |
Vmax |
61.0 |
None |
10.1021/jm00127a026 |
| Sus scrofa |
Sus scrofa |
Vmax |
100.0 |
None |
10.1021/jm00127a026 |
| None |
ADMET |
Km |
140.0 |
None |
10.1021/jm00105a070 |
| None |
ADMET |
Ratio |
1.0 |
None |
10.1021/jm00105a070 |
| None |
ADMET |
Relative Vmax |
1.0 |
None |
10.1021/jm00105a070 |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1021/tx1000865 |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1021/tx900326k |
| None |
Hepatotoxicity |
Hepatotoxicity |
nan |
None |
10.1124/dmd.110.035113 |
| None |
Hepatotoxicity |
HepSE_bilirubinemia |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholecystitis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cholelithiasis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_cirrhosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_Combined Scores |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_elevated liver function tests |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic failure |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatic necrosis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatitis |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_hepatomegaly |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_jaundice |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver disease |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver fatty |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
HepSE_liver function tests abnormal |
0.0 |
None |
10.1371/journal.pcbi.1002310 |
| None |
Hepatotoxicity |
LTKB_BD DILI severity score |
nan |
None |
10.1016/j.drudis.2011.05.007 |
| None |
No relevant target |
LogP |
-2.81 |
None |
10.1016/j.ejmech.2007.05.007 |
| None |
Phospholipidosis |
Phospholipidosis |
nan |
None |
10.1080/15376510701857262 |
| None |
Unchecked |
Ac50 |
2.239 |
uM |
None |
| None |
Unchecked |
Ac50 |
35.48 |
uM |
None |
| None |
Unchecked |
Ac50 |
44.67 |
uM |
None |
| None |
Unchecked |
AC50 |
2238.7 |
nM |
None |
| None |
Unchecked |
AC50 |
35481.3 |
nM |
None |
| None |
Unchecked |
AC50 |
44668.4 |
nM |
None |
| None |
Unchecked |
Activity |
95.0 |
% |
10.1016/j.bmcl.2008.10.129 |
| None |
Unchecked |
Activity |
nan |
None |
10.1016/j.bmcl.2019.05.047 |
| None |
Unchecked |
Kd |
1.0 |
nM |
10.1021/jm040187v |
| None |
Unchecked |
Ratio |
0.054 |
None |
10.1021/jm00040a008 |
| None |
Unchecked |
Ratio |
0.77 |
None |
10.1021/jm00113a011 |
| None |
Unchecked |
RBA |
1.0 |
None |
10.1016/j.ejmech.2018.12.035 |